Premium
O1–11–05: Pharmacological inhibition of the beta‐amyloid and apolipoprotein E interaction ameliorates Alzheimer's pathology in APPSW/PS1dE9 / APOE‐ε2‐TR and APPSW/PS1dE9 / APOE‐ε4‐TR mice
Author(s) -
Pankiewicz Joanna,
Kim Jungsu,
Ormazabal Maitea Guridi,
Sanchez Sandrine,
Granovetter Michael,
Sullivan Patrick,
Holtzman David,
Sadowski Martin
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.04.114
Subject(s) - apolipoprotein e , genetically modified mouse , medicine , endocrinology , amyloid beta , amyloid (mycology) , presenilin , apolipoprotein b , transgene , alzheimer's disease , pathology , chemistry , disease , cholesterol , biochemistry , gene